Institute Of Tropical Medicine, Belgium
Clinical trials sponsored by Institute Of Tropical Medicine, Belgium, explained in plain language.
-
Mpox vaccine trial targets HIV-Positive adults in DRC
Prevention OngoingThis study is testing whether the MVA-BN mpox vaccine is safe and triggers a strong immune response in 600 adults living with HIV in Kinshasa, DRC. Participants receive two vaccine doses 28 days apart and are grouped by their CD4 count. The goal is to see if the vaccine works wel…
Phase: PHASE2 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Mpox vaccine immune response under the microscope in DRC
Knowledge-focused OngoingThis study follows 300 adults in the Democratic Republic of the Congo who received either the MVA-BN or LC16m8 mpox vaccine as part of a national campaign. Researchers collect blood samples at several time points to measure how well the vaccines trigger and maintain antibodies ag…
Phase: PHASE4 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can tracking where people go stop dengue? new study says yes
Knowledge-focused OngoingThis study aims to improve how we predict and prevent dengue outbreaks by looking at how people move around the city. Researchers in Cuba will collect information from 810 residents about their daily travel, along with mosquito and weather data. The goal is to build better comput…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC